Immunohistochemistry

SJ Sean J Judge
MD Morgan A Darrow
ST Steve W Thorpe
AG Alicia A Gingrich
EO Edmond F O'Donnell
AB Alyssa R Bellini
IS Ian R Sturgill
LV Logan V Vick
CD Cordelia Dunai
KS Kevin M Stoffel
YL Yue Lyu
SC Shuai Chen
MC May Cho
RR Robert B Rebhun
AM Arta M Monjazeb
WM William J Murphy
RC Robert J Canter
ask Ask a question
Favorite

Tissue microarrays were constructed as described previously.26 Immunohistochemical (IHC) staining was performed using mouse anti-human CD3 (Abcam, clone SP7), mouse anti-human CD8 (Dako, clone C8/144B), rabbit anti-human TIGIT (Abcam, clone BLR047F), and mouse anti-human CD56 (Dako, clone 123C3). TIL and IHC expression scores were determined by a blinded pathologist (MAD). TIL scores were calculated on H&E-stained slides as follows: 3 (>20 TIL/high-power field (hpf)), 2 (11–20 TIL/hpf), 1 (1–10 TIL/hpf), 0 (<1 TIL/hpf). IHC expression for CD3, CD8, CD56, and TIGIT was calculated as follows to derive an H-score: [1x (% 1+cells)+2x(% 2+cells)+3x(% 3+cells)] where 1+, 2+, and 3+ represent weak, moderate, and strong stain intensity, respectively. Final TIL and IHC expression scores were averaged when more than one consecutive section was present for scoring. PD-L1 staining of tumor samples was performed using a CLIA-certified laboratory.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A